¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"free radical reductase"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • free zone
    ÀÚÀ¯ ¿µ¿ª, ºó ¿µ¿ª
  • free zone
    ºó °ø°£ (ÍöÊà)
  • free-air chamber
    ÀÚÀ¯°ø±âÇÔ
  • free-flowing effusion
    ÀÚÀ¯ À¯µ¿ »ïÃâ¾×
  • fusion-free position
    À¶ÇÕÁ¦°Å¾ÈÀ§
  • germ free
    ¹«±Õ
  • germ free animal
    ¹«±Õµ¿¹°.
  • gluten free diet
    ±Û·çÅÙ°áÇ̽Ä.
  • graft, free jejunal
    À¯¸®°øÀå À̽ļú
  • inosite free bouillon
    À̳ë½ÃÆ®°á¿©ºÎ¿ë.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • free joint articulator
    ÀÚÀ¯¿îµ¿±³ÇÕ±â(í»ë¦ê¡ÔÑÎáùêÐï).
  • free macrophage
    ÀÚÀ¯Å«Æ÷½Ä¼¼Æ÷, ÀÚÀ¯´ë½Ä¼¼Æ÷.
  • free macrophage
    ÀÚÀ¯Å«Æ÷½Ä¼¼Æ÷, ÀÚÀ¯´ë½Ä¼¼Æ÷.
  • free margin
    ÀÚÀ¯¸ð¼­¸®, ÀÚÀ¯¿¬(í»ë¦æÞ).
  • free margin
    ÀÚÀ¯¸ð¼­¸®
  • free margin of eyelid
    ¾È°Ë¿¬(äÑÌ¡æÞ).
  • free nerve ending
    ÀÚÀ¯½Å°æÁ¾¸».[½Å°æ]À¯¸®½Å°æÁ¾¸»(ë´ìÆãêÌèðûØÇ).
  • free nerve ending
    ÀÚÀ¯(í»ë¦)½Å°æÁ¾¸».½Å°æÀ¯¸®½Å°æÁ¾¸»(ë´ìÆãêÌèðûØÇ).
  • free nerve terminal
    ÀÚÀ¯½Å°æÁ¾¸».½Å°æÀ¯¸®½Å°æÁ¾¸»(ë´ìÆãêÌèðûØÇ).
  • free nerve terminal
    ÀÚÀ¯½Å°æÁ¾¸»
  • free nucleus
    À¯¸®ÇÙ(ë´ìÆú·).
  • free part
    ÀÚÀ¯ºÎºÐ
  • free phagocyte
    À¯ÁֽO÷.
  • free phagocyte
    À¯¸®½Ä¼¼Æ÷.
  • free pleural fluid
    ÀÚÀ¯ ´Á¸· »ïÃâ¾×
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
EGRAC erythrocyte glutathione reductase activity coefficient
GMPR guanine monophosphate reductase
GR gamma-rays; gastric resection; general research; generalized rash; glucocorticoid receptor; glutathi...
GSR galvanic skin response; generalized Shwartzman reaction; glutathione reductase
GSSG-R glutathione reductase
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
DRAT Dinitrogenase reductase ADP-ribosyltransferase
DRAG Dinitrogenase reductase-activating glycohydrolase
FNR Ferredoxin NADP+ reductase
FTR Ferredoxin-thioredoxin reductase
FRD Fumarate reductase
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
carboxylate reductase <enzyme> From pyrococcus furiosus; acts on glyceraldehyde to yield glycerate in a unique, partially nonphosphorylated, glycolytic pathway that generates acetyl-CoA from glucose without the participation of nicotinamide nucleotides
Registry number: EC 1.2.99.6
Synonym: glyceraldehyde ferredoxin oxidoreductase, tungsten-iron-sulfur protein, red tungsten protein
(26 Jun 1999)
carboxylic acid reductase <enzyme> Reduces double bonds in presence of hydrogen
Registry number: EC 1.3.99.-
(26 Jun 1999)
maleylacetate reductase <enzyme> Reduces maleylacetate to beta-ketoadipate, uses NADH
Registry number: EC 1.3.1.32
(26 Jun 1999)
GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase <enzyme> Forms GDP-l-fucose
Registry number: EC 5.1.3.-
Synonym: GDPkd epimerase-reductase
(26 Jun 1999)
mannose-6-phosphate reductase <enzyme> Involved in biosynthesis of mannitol in celery
Registry number: EC 1.1.1.224
Synonym: manp reductase
(26 Jun 1999)
reductase <enzyme> An enzyme that catalyses a reduction; since all enzymes catalyze reactions in either direction, any reductase can, under the proper conditions, behave as an oxidase and vice versa, hence the term oxidoreductase. For individual reductase's, see the specific names.
Synonym: reducing enzyme.
(05 Mar 2000)
cathenamine reductase <enzyme> Forms ajmalicine alkaloids from cathenamine
Registry number: EC 1.3.1.-
(26 Jun 1999)
CDP-6-deoxy-4-hexulose-3-dehydrase reductase <enzyme> Nadh-dependent enzyme that transfer of electrons to cdp-6-deoxy-l-threo-d-glycero-4-hexulose 3-dehydrase, which catalyses reduction of cdp-6-deoxy-delta(3,4)-glucoseen to cdp-4-keto-3,6-dideoxy-d-glucose
Registry number: EC 1.3.1.-
Synonym: ckdg dehydrase reductase, cdp--6-deoxy-l-threo-d-glycero-4-hexulose-3-dehydrase reductase
(26 Jun 1999)
CDP-6-deoxy-delta(3,4)-glucoseen reductase <enzyme> Key enzyme catalyzing the biosynthetic formation of cdp-ascarylose via a pyridoxamine-linked intermediate; the enzyme can also oxidise NADPH in the presence of oxygen; from yerisinia pseudotuberculosis
Registry number: EC 1.17.1.-
Synonym: cddg reductase
(26 Jun 1999)
CDP reductase <enzyme> Includes deoxy analog
Registry number: EC 1.17.4.-
Synonym: cytidine diphosphate reductase, deoxycytidine diphosphate reductase
(26 Jun 1999)
glucuronate reductase <enzyme> Alpha-1-6 in the presence of alpha-1,3 glucosidic linkages; text
Registry number: EC 1.1.1.19
Synonym: glucuronoreductase, hexonate dehydrogenase
(26 Jun 1999)
glutamyl tRNA reductase <enzyme> Involved in aminolevulinic acid biosynthesis; trna is cofactor for NADPH-dependent reduction of glutamate to glutamate-1-saemialdehyde; amino acid sequence given in second source
Registry number: EC 1.2.1.-
Synonym: glu-trna reductase, haema protein, haema gene product, k-12 haema gene product, haema1 gene product, haema2 gene product
(26 Jun 1999)
glutathione reductase <enzyme> An FAD containing enzyme, a dimer of 50 kD subunits.
It catalyses the NADP dependent reduction of glutathione disulphide (GSSG) to glutathione (GSH). This is an essential reaction that maintains a GSH:GSSG ratio in the cytoplasm of _500:1.
(18 Nov 1997)
glyceryl trinitrate reductase <enzyme> May be an enzyme system; from fungus phanerochaete chrysosporium; requires NADPH; forms glyceryl dinitrates, and ultimately, glyceryl mononitrates and no
Registry number: EC 1.7.3.-
Synonym: gtn-reductase, glycerol trinitrate reductase, gtn reductase
(26 Jun 1999)
glycine reductase <enzyme> Glycine is reductively deaminated to acetate and ammonia by a complex requiring a dithiol and synthesizing ATP
Registry number: EC 1.4.1.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á